NasdaqCM - Delayed Quote USD
BeyondSpring Inc. (BYSI)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:09 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.44 | -0.49 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | 30M | 340k | 1.35M | 1.4M |
| Low Estimate | 30M | 340k | -- | 1.4M |
| High Estimate | 30M | 340k | 31.01M | 1.4M |
| Year Ago Sales | 338k | 338k | 1.35M | 1.35M |
| Sales Growth (year/est) | 8,775.70% | 0.60% | 0.00% | 3.60% |
Earnings History
| CURRENCY IN USD | 3/31/2021 | 6/30/2021 | 9/30/2021 | 12/31/2021 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.33 | -0.37 | -0.26 |
| EPS Actual | -0.44 | -0.49 | -0.47 | -0.24 |
| Difference | 0.1 | -0.16 | -0.1 | 0.02 |
| Surprise % | 18.50% | -48.50% | -27.00% | 7.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
| 30 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
| 60 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
| 90 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BYSI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.70% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | -- | -- | -- | 2.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -159.60% | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Baird: Outperform | 5/2/2023 |
| Downgrade | Jefferies: Buy to Hold | 12/2/2021 |
| Downgrade | B of A Securities: Buy to Underperform | 12/2/2021 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/1/2021 |
| Maintains | HC Wainwright & Co.: Buy | 9/20/2021 |
| Initiated | Baird: Outperform | 9/9/2021 |
Related Tickers
XLO Xilio Therapeutics, Inc.
0.7790
-2.38%
KPTI Karyopharm Therapeutics Inc.
0.8701
+1.89%
CARA Cara Therapeutics, Inc.
0.2651
-0.64%
ERAS Erasca, Inc.
2.9100
+3.93%
ELVN Enliven Therapeutics, Inc.
29.00
+3.50%
GLUE Monte Rosa Therapeutics, Inc.
5.52
+0.55%
GYRE Gyre Therapeutics, Inc.
14.06
+0.29%
YMAB Y-mAbs Therapeutics, Inc.
14.45
+1.76%
GBIO Generation Bio Co.
2.2600
-2.16%
FENC Fennec Pharmaceuticals Inc.
4.5400
-2.37%